Applications of DL-Citrulline in Industrial Manufacturing

As a direct manufacturer of DL-Citrulline, we serve industrial partners across rigorously regulated sectors. This section details specific B2B application scenarios, with technical context and formulation intelligence informed by real-world production processes and compliance frameworks.

1. Sports Nutrition Ingredient Manufacturing

DL-Citrulline functions as a non-essential amino acid compound in the sports supplement sector, primarily utilized for powdered blends and performance-related formulations. Manufacturers apply it in pre-workout powders, nitric oxide boosters, and functional beverages, leveraging its properties to support blood flow and muscle metabolism. Precision in dosing and documentation is critical to align with the evolving regulatory requirements for sports nutrition, with batch records and analytical controls maintained throughout production.

Industry compliance standards

• EU Regulation (EC) No 1924/2006 on nutrition and health claims
• U.S. FDA Dietary Supplement Health and Education Act (DSHEA) stipulations
• China GB 2760-2014 National Food Safety Standard - Standards for Uses of Food Additives
• ISO 22000 Food Safety Management System

Typical usage ratio

• 1.5% – 5% by weight in powdered or tablet formulations
• Levels adjusted according to serving size, flavor integration, and interaction with other amino acids

Downstream process integration

• Dry blending after all powders reach uniform particle size
• Tableting using direct compression, ensuring even distribution
• Premix addition in beverage concentrates, prior to liquid bottling
• Ongoing QC with HPLC-based purity and homogeneity tests

Final product types

• Pre-workout powders
• Effervescent tablets
• Ready-to-mix sports drink sachets
• Amino acid premix blends for contract manufacture

2. Pharmaceutical Grade Amino Acid Preparation

In pharmaceutical manufacturing, DL-Citrulline must meet stringent monograph specifications for inclusion in medical nutrition therapy, oral amino acid supplements, and clinical formulations. All operations must trace each batch from incoming raw material inspection to final tableting or filling, with stability studies and impurity profiles documented per regulatory dossiers.

Industry compliance standards

• USP–NF (United States Pharmacopeia–National Formulary) amino acid grade monograph
• EP (European Pharmacopoeia) monograph for non-proteinogenic amino acids
• WHO GMP requirements for pharmaceutical ingredients
• China Pharmacopoeia ChP 2020 Medicine and Pharmaceutical Ingredients

Typical usage ratio

• 0.5 g – 3 g per tablet or capsule dosage unit
• Typically 2% – 6% by weight in bulk oral nutrition blends
• Dose tailored based on patient age and indication

Downstream process integration

• Accurate weighing and sifting into the blending step
• Blending with direct compression excipients or suspension agents
• Granulation before tablet compression, or dissolved for liquid filling
• Continuous stability and particle size monitoring in cleanroom

Final product types

• Oral amino acid tablets
• Enteral feeding powder supplements
• Infant metabolic disorder therapy blends
• Clinical nutrition syrups

3. Food Fortification and Functional Beverage Production

DL-Citrulline sees targeted use in the enrichment of specialty foods and beverage matrices, where it contributes to formulation claims such as “amino acid fortified” or “muscle recovery support.” Food technologists incorporate it during batch beverage compounding or dry food blending, prioritizing both palatability and label compliance, while ensuring no off-flavor development over product shelf life.

Industry compliance standards

• FDA 21 CFR 170 – Food Additives regulations
• EU Regulation (EC) No 1333/2008 on additives
• GB 14880-2012 China National Food Safety Standard for the Use of Nutritional Fortification Substances
• HACCP and FSSC 22000 certification for production lines

Typical usage ratio

• 0.2% – 2.0% by weight, adjusted for label claim and organoleptic testing
• Up to 1 g per 250 ml beverage serving; food blend rates based on serving format

Downstream process integration

• Incorporated during liquid beverage concentrate make-up, mixing until full solubilization
• Added after cooking step in protein bars or snack blends to retain functional properties
• Dissolved with other micronutrients in custom powder blends prior to dry packing
• Sensory and fortification testing on each production lot

Final product types

• Functional hydration beverages
• RTD (ready-to-drink) energy shots
• Protein-enriched snack foods
• High amino acid meal replacements

4. Veterinary and Animal Feed Formulation

DL-Citrulline is utilized by specialty feed and pet nutrition manufacturers as a supplemental amino acid in dietary formulations, especially for growth or metabolic support in livestock and companion animals. Feed integrators precisely meter additions at the premix or compound stage, referencing regulatory guidelines to avoid excess intake and cross-contamination in multi-product facilities.

Industry compliance standards

• AAFCO (Association of American Feed Control Officials) guidelines for amino acid supplementation
• EU Regulation (EC) No 1831/2003 on additives for animal nutrition
• Chinese GB/T 31222-2014 Feed Additive—Amino Acid
• ISO 22000 HACCP certified animal feed plants

Typical usage ratio

• 0.01% – 0.2% based on dry feed weight; species- and growth-stage-specific dosing
• Higher end of dosage range in veterinary therapeutic feeds; lower in baseline rations

Downstream process integration

• Blended with base amino acid premixes prior to extrusion or pelleting
• Added after ingredient grinding, prior to moisture conditioning
• Incorporated into liquid feed supplements post-dissolution
• Batch samples subject to amino acid profile validation

Final product types

• Complete animal feed formulations
• Veterinary oral supplements
• Pet nutritional powders and chews
• Specialist livestock growth promoters

5. Biomedical and Cell Culture Media Preparation

Research-grade and clinical cell culture producers require DL-Citrulline as a defined component in custom media recipes for cellular metabolism studies and tissue engineering workflows. Formulation precision, component traceability, and endotoxin control are emphasized, as are compatibility checks with other cell culture reagents during reconstitution and sterilization.

Industry compliance standards

• ISO 13485 Medical Device Quality Management
• USP <1043> Ancillary Materials for Cell, Gene, and Tissue-Engineered Products
• Ph. Eur. 5.2.12 Cell-based medicinal product controls
• Internal QC specifications for bioprocess media suppliers

Typical usage ratio

• 5 mg/L – 25 mg/L in aqueous cell culture solutions
• Adjustment based on cell line and metabolic pathway focus

Downstream process integration

• Dissolved in sterile water during custom media formulation
• Added to media concentrates immediately before filtration and sterile bottling
• Batchwise addition to bioreactor feeds for experimental designs
• QC screening for endotoxin, cell viability response, and true amino acid content

Final product types

• Custom cell culture media powders
• Serum-free bioprocessing liquids
• Tissue engineering culture kits
• Biological test kits for research and clinical use